Paratek Pharmaceuticals Inc Logo Image

Paratek Pharmaceuticals Inc

Paratek Pharmaceuticals Inc Banner Image

Most Recent Annual Report

2019 Annual Report and Form 10K

Paratek Pharmaceuticals Inc

Paratek Pharmaceuticals Inc has reached its limit for free report views.

Paratek Pharmaceuticals Inc does not currently have any hardcopy reports on Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Paratek Pharmaceuticals Inc

11-50 Employees
Based in Boston, Massachusetts

Paratek Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of antibacterial therapeutics based upon tetracycline chemistry in the United States. Its lead product candidate, omadacycline, is a tetracycline-derived and broad-spectrum antibiotic developed in oral tablet and intravenous formulations for use as a monotherapy antibiotic for acute bacterial skin and skin structure infections (ABSSSI), community-acquired bacterial pneumonia (CABP), urinary tract infections, and other serious community-acquired bacterial infections.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol